Lowest Price Guaranteed From USD 5,499
Published
September 2021
Pages
125
View Count
1360
Example Insights
Report Description
The “Thoracic Aortic Aneurysm: Pipeline Review, Developer Landscape and Competitive Insights, 2021-2031” report features an extensive study on the marketed, clinical and preclinical molecules available / being developed for the treatment of Thoracic Aortic Aneurysm.
This report provides an in-depth analysis of the product pipeline and developer companies, highlighting the current treatment practices, emerging drugs, and market share of the individual therapies. In addition to other elements, the study includes detailed assessment of the current market landscape, providing information about the product’s mechanism of action, dosage and administration, and pharmacological studies, regulatory milestones, and other development activities.
One of the key objectives of the report was to estimate the existing market size and the future opportunity of therapies for Thoracic Aortic Aneurysm, over the next decade. Based on multiple parameters, such as disease prevalence, anticipated adoption of the forecasted therapies and the likely selling price of such therapeutic products, we have provided informed estimates on the evolution of the market for the period 2021-2031.
Contents
1. Preface
2. Executive Summary
3. Introduction
4. Pipeline Review
4.1. Chapter Overview
4.2. Thoracic Aortic Aneurysm: Development Pipeline
4.3. Thoracic Aortic Aneurysm: Pipeline Analysis
4.3.1. Analysis by Phase of Development
4.3.2. Analysis by Drug Class
4.3.3. Analysis by Route of Administration
4.3.4. Analysis by Mechanism of Action
4.4. Thoracic Aortic Aneurysm: Developers
4.4.1. Analysis by Year of Establishment
4.4.2. Analysis by Company Size
4.4.3. Analysis by Geographical Location
5. Company Profiles
6. KOL Analysis
7. Partnerships and Collaborations
8. Funding and Investment Analysis
9. Clinical Trials Analysis
10. Market Sizing and Opportunity Analysis
11. Executive Insights
12. Concluding Remarks
13. Appendix 1: Tabulated Data
14. Appendix 2: List of Companies and Organizations